540679 Stock Overview Manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
SMS Lifesciences India Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for SMS Lifesciences India Historical stock prices Current Share Price ₹1,199.50 52 Week High ₹1,747.85 52 Week Low ₹495.00 Beta 0.90 1 Month Change 19.12% 3 Month Change -22.25% 1 Year Change 135.29% 3 Year Change 54.67% 5 Year Change 354.87% Change since IPO 707.20%
Recent News & Updates
Insufficient new directors Dec 01
Investor sentiment improves as stock rises 21% Nov 28
Second quarter 2025 earnings released: EPS: ₹15.46 (vs ₹2.20 in 2Q 2024) Nov 15
Investor sentiment deteriorates as stock falls 17% Nov 13
SMS Lifesciences India Limited to Report Q2, 2025 Results on Nov 13, 2024 Nov 09
Investor sentiment deteriorates as stock falls 16% Oct 22 See more updates
Insufficient new directors Dec 01
Investor sentiment improves as stock rises 21% Nov 28
Second quarter 2025 earnings released: EPS: ₹15.46 (vs ₹2.20 in 2Q 2024) Nov 15
Investor sentiment deteriorates as stock falls 17% Nov 13
SMS Lifesciences India Limited to Report Q2, 2025 Results on Nov 13, 2024 Nov 09
Investor sentiment deteriorates as stock falls 16% Oct 22
Upcoming dividend of ₹1.50 per share Sep 16
Investor sentiment improves as stock rises 17% Sep 06
Dividend of ₹1.50 announced Aug 28
Investor sentiment improves as stock rises 16% Aug 16
First quarter 2025 earnings released: EPS: ₹23.15 (vs ₹5.94 loss in 1Q 2024) Aug 10
SMS Lifesciences India Limited, Annual General Meeting, Sep 30, 2024 Aug 09
SMS Lifesciences India Limited to Report Q1, 2025 Results on Aug 09, 2024 Aug 06
Board Member recently bought ₹5.3m worth of stock Jul 04
New minor risk - Share price stability May 28
Investor sentiment improves as stock rises 24% May 28
SMS Lifesciences India Limited to Report Q4, 2024 Results on May 27, 2024 May 23
Board Member recently bought ₹10.0m worth of stock Apr 02
Third quarter 2024 earnings released: EPS: ₹14.24 (vs ₹13.18 in 3Q 2023) Feb 11
SMS Lifesciences India Limited to Report Q3, 2024 Results on Feb 10, 2024 Feb 03
Second quarter 2024 earnings released: EPS: ₹2.20 (vs ₹10.33 in 2Q 2023) Nov 13
SMS Lifesciences India Limited to Report Q2, 2024 Results on Nov 11, 2023 Nov 05
Upcoming dividend of ₹1.50 per share at 0.3% yield Sep 15
SMS Lifesciences India Limited, Annual General Meeting, Sep 29, 2023 Aug 09
New minor risk - Earnings quality Aug 09
First quarter 2024 earnings released: ₹5.94 loss per share (vs ₹9.95 profit in 1Q 2023) Aug 09 SMS Lifesciences India Limited to Report Q1, 2024 Results on Aug 08, 2023 Aug 03
SMS Lifesciences India Limited Recommends Dividend for the Year 2022-23 May 31
Full year 2023 earnings released: EPS: ₹37.92 (vs ₹83.76 in FY 2022) May 31
SMS Lifesciences India Limited to Report Q4, 2023 Results on May 29, 2023 May 23
Third quarter 2023 earnings released: EPS: ₹13.18 (vs ₹7.70 in 3Q 2022) Feb 12
SMS Lifesciences India Limited Announces Resignation of Venkafasubbarao Polluri as Independent Director from the Board and Member of Audit Committee Feb 11
SMS Lifesciences India Limited to Report Q3, 2023 Results on Feb 10, 2023 Feb 04
Second quarter 2023 earnings released: EPS: ₹10.33 (vs ₹33.91 in 2Q 2022) Nov 19
SMS Lifesciences India Limited Approves Dividend for the Year 2021-2022 Oct 02
Upcoming dividend of ₹1.50 per share Sep 15
SMS Lifesciences India Limited Proposes Dividend for Year 2021-22 Sep 09
First quarter 2023 earnings released: EPS: ₹9.95 (vs ₹12.00 in 1Q 2022) Aug 11
SMS Lifesciences India Limited, Annual General Meeting, Sep 30, 2022 Aug 10
Board Member recently bought ₹16m worth of stock Jun 25
Full year 2022 earnings released: EPS: ₹83.68 (vs ₹44.84 in FY 2021) May 30
SMS Lifesciences India Limited to Report Q4, 2022 Results on May 28, 2022 May 22
Investor sentiment improved over the past week Apr 11
Insider recently bought ₹4.8m worth of stock Apr 03
Insider recently bought ₹1.8m worth of stock Mar 13
Board Member recently bought ₹16m worth of stock Feb 28
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 13
Chemwerth, Inc. acquired 10% stake in Mahi Drugs Private Limited from SMS Lifesciences India Limited (NSEI:SMSLIFE). Dec 01
Insider recently sold ₹1.7m worth of stock Nov 03
Investor sentiment improved over the past week Oct 28
Investor sentiment improved over the past week Oct 04
Upcoming dividend of ₹1.50 per share Sep 13
Non-Executive & Independent Director Neelaveni Thummala has left the company Sep 06
Insider recently sold ₹2.3m worth of stock Jul 01
Non-Executive Director Ramesh Potluri has left the company Jun 29
Investor sentiment improved over the past week Jun 25
Full year 2021 earnings released: EPS ₹44.84 (vs ₹33.68 in FY 2020) Jun 20
Investor sentiment improved over the past week Apr 23
Investor sentiment improved over the past week Apr 07
New 90-day low: ₹538 Feb 22
Third quarter 2021 earnings released: EPS ₹8.92 (vs ₹1.12 loss in 3Q 2020) Feb 13
SMS Lifesciences India Limited to Report Q3, 2021 Results on Feb 12, 2021 Feb 08
New 90-day low: ₹540 Jan 28
MD & Executive Director recently bought ₹57m worth of stock Dec 13
Market bids up stock over the past week Dec 07
New 90-day high: ₹693 Dec 07
MD & Executive Director recently bought ₹51m worth of stock Nov 27
Market bids up stock over the past week Nov 11
SMS Lifesciences India Limited to Report Q2, 2021 Results on Nov 13, 2020 Nov 07
New 90-day high: ₹667 Oct 19
Non-Executive Director recently sold ₹38m worth of stock Oct 02
New 90-day high - ₹500 Sep 15
SMS Lifesciences India Limited Decides Not to Recommend Dividend for the Financial Year Ended 31 March, 2020 Sep 09
First quarter earnings released Aug 24
New 90-day high - ₹474 Aug 21
SMS Lifesciences India Limited to Report Q1, 2021 Results on Aug 21, 2020 Aug 15
New 90-day high - ₹404 Aug 03 Shareholder Returns 540679 IN Pharmaceuticals IN Market 7D 0.02% 0.8% -4.3% 1Y 135.3% 39.7% 19.1%
See full shareholder returns
Return vs Market: 540679 exceeded the Indian Market which returned 19.1% over the past year.
Price Volatility Is 540679's price volatile compared to industry and market? 540679 volatility 540679 Average Weekly Movement 6.9% Pharmaceuticals Industry Average Movement 6.0% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 540679 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 540679's weekly volatility (7%) has been stable over the past year.
About the Company Founded Employees CEO Website 1990 574 Talluri Veera Venkata Murthy www.smslife.in
SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as anti ulcer, erectile dysfunction, anti gout, anesthesia, anti infective, anti obesity, antifungal, anti convulsant, anti emetic, ophthalmic, anti worm, and antiemetic. It is also developing APIs in the areas of anti depressant, anti psychotic, anti hypertension, veterinary, antiviral, and anticoagulant.
Show more SMS Lifesciences India Limited Fundamentals Summary How do SMS Lifesciences India's earnings and revenue compare to its market cap? 540679 fundamental statistics Market cap ₹3.64b Earnings (TTM ) ₹218.79m Revenue (TTM ) ₹3.17b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 540679 income statement (TTM ) Revenue ₹3.17b Cost of Revenue ₹2.01b Gross Profit ₹1.16b Other Expenses ₹939.00m Earnings ₹218.79m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 72.37 Gross Margin 36.54% Net Profit Margin 6.90% Debt/Equity Ratio 44.0%
How did 540679 perform over the long term?
See historical performance and comparison Dividends
0.1% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 06:14 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources SMS Lifesciences India Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Kameswari V. S. Chavali FirstCall Research
Show 0 more analysts 
